2013
DOI: 10.1007/s10875-013-9977-z
|View full text |Cite
|
Sign up to set email alerts
|

Measurement of Pneumococcal Polysaccharide Antibodies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0

Year Published

2015
2015
2019
2019

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 11 publications
(15 citation statements)
references
References 7 publications
0
15
0
Order By: Relevance
“…A comparison of pneumococcal polysaccharide antibody response and S. typhi Vi vaccine response was recently conducted in 16 healthy volunteers, 22 common variable immunodeficiency patients, and 27 hypogammaglobulinemic patients and showed superiority of anti- S. typhi Vi vaccine responses to discriminate between groups. However, pneumococcal response was assessed by a commercial PPV-coated ELISA and these ELISAs, measuring a combined IgG response, have limited value to diagnose patients with SAD (13). Using the same commercial ELISA kit for S. typhi Vi vaccine, Sánchez-Ramón and colleagues found a minimum postvaccination IgG concentration of 32 and 7.4 U/ml and minimum fold increase of 3.4 and 1 in a healthy and Common Variable Immunodeficiency group, respectively, which shows that our proposed criteria discriminate healthy subjects from SAD subjects (16).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…A comparison of pneumococcal polysaccharide antibody response and S. typhi Vi vaccine response was recently conducted in 16 healthy volunteers, 22 common variable immunodeficiency patients, and 27 hypogammaglobulinemic patients and showed superiority of anti- S. typhi Vi vaccine responses to discriminate between groups. However, pneumococcal response was assessed by a commercial PPV-coated ELISA and these ELISAs, measuring a combined IgG response, have limited value to diagnose patients with SAD (13). Using the same commercial ELISA kit for S. typhi Vi vaccine, Sánchez-Ramón and colleagues found a minimum postvaccination IgG concentration of 32 and 7.4 U/ml and minimum fold increase of 3.4 and 1 in a healthy and Common Variable Immunodeficiency group, respectively, which shows that our proposed criteria discriminate healthy subjects from SAD subjects (16).…”
Section: Discussionmentioning
confidence: 99%
“…Since the introduction of the conjugated pneumococcal vaccine for routine immunization of children, in most industrialized countries, even more individuals have been primed with conjugated polysaccharides (11, 12). Therefore, the measurement of pneumococcal polysaccharide antibodies may no longer be the preferable assessment of the T-independent response (13). Other limitations include cost, workload, and concerns about hyporesponsiveness to polysaccharide vaccines with subsequent administrations (14).…”
Section: Introductionmentioning
confidence: 99%
“…13 The interpretation of an adequate or inadequate response to PPV23 has been recommended by experts in the field using this cutoff, 29 but strict definitions based on 1.3 mg/mL should not be used with multiplex results. 30 Results obtained with multiplex assays are not equivalent to ELISA and may poorly correlate. 31 The method a laboratory uses for measurement of pneumococcal antibody titers when interpreting results is important because most commercial laboratories use multiplex methods because they are high throughput.…”
Section: Vaccine Titer Responsesmentioning
confidence: 99%
“…Clinical validation of the usefulness of Luminex is still in progress. 18,19 PPV23 has the advantage that a high number of serotypes are included, disallowing a diagnosis based on a single antigen response. Measurement of total antipneumococcal IgG in a single test that produces 1 numeric value without differentiating specific antibodies to individual serotypes is not useful.…”
Section: Specific Antibody Deficienciesmentioning
confidence: 99%